HomeABCL • NASDAQ
add
AbCellera Biologics Inc
$2.57
Makalipas ang Oras ng Trabaho:(0.78%)+0.020
$2.59
Sarado: Abr 25, 8:00:00 PM GMT-4 · USD · NASDAQ · Disclaimer
Nakaraang pagsara
$2.60
Sakop ng araw
$2.54 - $2.64
Sakop ng taon
$1.89 - $4.34
Market cap
765.83M USD
Average na Volume
4.00M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
(USD) | Dis 2024info | Y/Y na pagbabago |
---|---|---|
Kita | 5.05M | -44.98% |
Gastos sa pagpapatakbo | -271.00K | -101.02% |
Net na kita | -34.21M | 27.44% |
Net profit margin | -677.43 | -31.88% |
Kita sa bawat share | -0.12 | 25.00% |
EBITDA | -26.04M | 55.50% |
Aktuwal na % ng binabayarang buwis | 26.95% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
(USD) | Dis 2024info | Y/Y na pagbabago |
---|---|---|
Cash at mga panandaliang investment | 625.61M | -17.75% |
Kabuuang asset | 1.36B | -8.57% |
Kabuuang sagutin | 304.47M | -9.32% |
Kabuuang equity | 1.06B | — |
Natitirang share | 297.99M | — |
Presyo para makapag-book | 0.73 | — |
Return on assets | -7.40% | — |
Return on capital | -8.97% | — |
Cash Flow
Net change in cash
(USD) | Dis 2024info | Y/Y na pagbabago |
---|---|---|
Net na kita | -34.21M | 27.44% |
Cash mula sa mga operasyon | -8.00M | 59.21% |
Cash mula sa pag-invest | 35.70M | 246.79% |
Cash mula sa financing | 4.14M | 10.01% |
Net change in cash | 29.68M | 175.92% |
Malayang cash flow | -72.44M | -28,861.47% |
Tungkol
AbCellera Biologics Inc. is a Vancouver, British Columbia-based contract research organization that is contracted by biotechnology and pharmaceutical companies for antibody services, and researches and develops human antibodies as a service for its clients. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia. Wikipedia
CEO
Itinatag
2012
Headquarters
Website
Mga Empleyado
596